Tumor necrosis factor alpha signaling pathway and apoptosis in pancreatic β cells

Metabolism: Clinical and Experimental

Volumn 48, Issue 12, 1999, Pages 1485-1492

  Ishizuka, Nobuko ^b   Yagui, Kazuo ^b   Tokuyama, Yoshiharu ^b   Yamada, Katsumi ^b   Suzuki, Yoshifumi ^b   Miyazaki, Jun Ichi ^b   Hashimoto, Naotake ^b   Makino, Hideichi ^b   Saito, Yasushi ^b   Kanatsuka, Azuma ^a  

^a Kasori Hospital   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACYLSPHINGOSINE DEACYLASE; CYTOKINE; FAS ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; ARTICLE; CELL DEATH; DNA DAMAGE; DNA DETERMINATION; DNA STRAND BREAKAGE; DOSE TIME EFFECT RELATION; HUMAN; HUMAN CELL; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 13044283437     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(99)90234-2     Document Type: Article

References (42)

1. Mandrup-Poulsen T, Bendtzen K, Nielsen JH, et al: Cytokines cause functional and structural damage to isolated islets of Langerhans. Allergy 40:424-429, 1985
2. Rabinovitch A, Suarez-Pinzon WL, Shi Y, et al: DNA fragmentation is an early event in cytokine-induced islet beta-cell destruction. Diabetologia 37:733-738, 1994
3. Tartaglia LA, Weber RF, Figari IS, et al: The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc Natl Acad Sci USA 88:9292-9296, 1991
4. Tartaglia LA, Ayres TM, Wong GHW, et al: A novel domain within the 55 kD TNF receptor signals cell death. Cell 74:845-853, 1993
5. Hsu H, Xiong J, Goeddel DV: The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell 81:495-504, 1995
6. Boldin MP, Varfolomeev EE, Pancer Z, et al: A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem 270:7795-7798, 1995
7. Stanger BZ, Leder P, Lee T-H, et al: RIP: A novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 81:513-523, 1995
8. Hannun YA: The sphingomyelin cycle and the second messenger function of ceramide. J Biol Chem 269:3125-3128, 1994
9. Kolesnick R, Golde DW: The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 77:325-328, 1994
10. Obeid LM, Linardic CM, Karolak LA, et al: Programmed cell death induced by ceramide. Science 259:1769-1771, 1993
11. Santana P, Llanes L, Hernandez I, et al: Ceramide mediates tumor necrosis factor effects on P450-aromatase activity in cultured granulosa cells. Endocrinology 136:2345-2348, 1995
12. Miyazaki J, Araki K, Yamato E, et al: Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: Special reference to expression of glucose transporter isoforms. Endocrinology 127:126-132, 1990
13. Kanatsuka A, Makino H, Yamaguchi T, et al: Islet amyloid polypeptide/amylin in pancreatic beta-cell line derived from transgenic mouse insulinoma. Diabetes 41:1409-1414, 1992
14. Ji L, Zhang G, Uematsu S, et al: Induction of apoptotic DNA fragmentation and cell death by natural ceramide. FEBS Lett 358:211-214, 1995
15. Weston SA, Parish CR: New fluorescent dyes for lymphocyte migration studies. Analysis by flow cytometry and fluorescence microscopy. J Immunol Methods 133:87-97, 1990
16. Jacobson MD, Burne JF, Raff MC: Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J 13:1899-1910, 1994
17. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501, 1992
18. Wijsman JH, Jonker RR, Keijzer R, et al: A new method to detect apoptosis in paraffin sections: In situ end-labeling of fragmented DNA. J Histochem Cytochem 41:7-12, 1993
19. James SJ, Muskhelishvili L: Rates of apoptosis and proliferation vary with caloric intake and may influence incidence of spontaneous hepatoma in C57BL/6 X C3H F1 mice. Cancer Res 54:5508-5510, 1994
20. Preiss J, Loomis CR, Bishop WR, et al: Quantitative measurement of sn-1,2-diacylglycerols present in platelets, hepatocytes, and ras- and sis-transformed normal rat kidney cells. J Biol Chem 261:8597-8600, 1986
21. Okazaki T, Bielawska A, Bell RM, et al: Role of ceramide as a lipid mediator of 1α,25-dihydroxyvitamin D3-induced HL-60 cell differentiation. J Biol Chem 265:15823-15831, 1990
22. Van Veldhoven PP, Bishop WR, Yurivich DA, et al: Ceramide quantitation: Evaluation of a mixed micellar assay using E. coli diacylglycerol kinase. Biochem Mol Biol Int 36:21-30, 1995
23. Muzio M, Chinnaiyan AM, Kischkel FC, et al: FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85:817-827, 1996
24. Hsu H, Shu H-B, Pan M-G, et al: TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84:299-308, 1996
25. Wyllie AH: Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284:555-556, 1980
26. Delaney CA, Green MHL, Lowe JE, et al: Endogenous nitric oxide induced by interleukin-1β in rat islets of Langerhans and HIT-T15 cells causes significant DNA damage as measured by the 'comet' assay. FEBS Lett 333:291-295, 1993
27. Wright SC, Kumar P, Tam AW, et al: Apoptosis and DNA fragmentation precede TNF-induced cytolysis in U937 cells. J Cell Biochem 48:344-355, 1992
28. Sugarman BJ, Aggarwal BB, Hass PE, et al: Recombinant human tumor necrosis factor alpha: Effects on proliferation of normal and transformed cells in vitro. Science 230:943-945, 1985
29. Hudziak RM, Lewis GD, Shalaby MR, et al: Amplified expression of the HER2/ERBB2 oncogene induces resistance to tumor necrosis factor-α in NIH3T3 cells. Proc Natl Acad Sci USA 85:5102-5106, 1988
30. Chen MJ, Holskin B, Strickler J, et al: Induction by EIA oncogene expression of cellular susceptibility to lysis by TNF. Nature 330:581-583, 1987
31. Fernandez A, Marin MC, McDonnell T, et al: Differential sensitivity of normal and Ha-ras-transformed C3H mouse embryo fibroblasts to tumor necrosis factor: Induction of bcl-2, c-myc, and manganese superoxide dismutase in resistant cells. Oncogene 9:2009-2017, 1994
32. Loetscher H, Pan YC, Lahm HW, et al: Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell 61:351-359, 1990
33. Nicholson DW, Ali A, Thornberry NA, et al: Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37-43, 1995
34. Chinnaiyan AM, Tepper CG, Seldin MF, et al: FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J Biol Chem 271:4961-4965, 1996
35. Boldin MP, Goncharov TM, Goltsev YV, et al: Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/Apo-1-and TNF receptor-induced cell death. Cell 85:803-815, 1996
36. Jarvis WD, Kolesnick RN, Fornari FA, et al: Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway. Proc Natl Acad Sci USA 91:73-77, 1994
37. Hartfield PJ, Mayne GC, Murray AW: Ceramide induces apoptosis in PC12 cells. FEBS Lett 401:148-152, 1997
38. Hannun YA, Bell RM: Functions of sphingolipids and sphingolipid breakdown products in cellular regulation. Science 243:500-507, 1989
39. Wiegmann K, Schütze S, Machleidt T, et al: Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 78:1005-1015, 1994
40. Jayadev S, Liu B, Bielawska AE, et al: Role for ceramide in cell cycle arrest. J Biol Chem 270:2047-2052, 1995
41. Dressler KA, Mathias S, Kolesnick RN: Tumor necrosis factor-α activates the sphingomyelin signal transduction pathway in a cell-free system. Science 255:1715-1718, 1992
42. Smyth MJ, Perry DK, Zhang J, et al: prICE: A downstream target for ceramide-induced apoptosis and for the inhibitory action of Bcl-2. Biochem J 316:25-28, 1996